Home / BCHE Knockout Cell Lines

BCHE Knockout Cell Lines

Gene: BCHE

Official Full Name: butyrylcholinesteraseprovided by HGNC

Gene Summary: This gene encodes a cholinesterase enzyme and member of the type-B carboxylesterase/lipase family of proteins. The encoded enzyme exhibits broad substrate specificity and is involved in the detoxification of poisons including organophosphate nerve agents and pesticides, and the metabolism of drugs including cocaine, heroin and aspirin. Humans homozygous for certain mutations in this gene exhibit prolonged apnea after administration of the muscle relaxant succinylcholine. [provided by RefSeq, Jul 2016]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
GP00606 BCHE gRNA1-gRNA2 KO plasmid BCHE $850
KO00647 BCHE Knockout cell line(Hep G2) Human BCHE 1:2~1:4 Negative Online Inquiry
KO00821 BCHE Knockout cell line (HeLa) Human BCHE 1:3~1:6 Negative Online Inquiry
KO19464 BCHE Knockout cell line (HEK293) Human BCHE 1:3~1:6 Negative Online Inquiry
KO19465 BCHE Knockout cell line (A549) Human BCHE 1:3~1:4 Negative Online Inquiry

Background

BCHE Gene Knockout Cell Lines are genetically modified cell lines where the butyrylcholinesterase (BCHE) gene has been intentionally disrupted, creating a valuable tool for researchers investigating cholinergic signaling pathways and pharmacological studies. BCHE is an important enzyme involved in the hydrolysis of choline esters, including acetylcholine, and its knockout allows for the exploration of physiological and pathological states where cholinergic activity is altered.

The mechanism of action centers on the absence of the BCHE enzyme, which provides a unique model for studying cellular responses to cholinergic stimuli and evaluating the effects of compounds that modulate cholinergic systems. Without the activity of BCHE, researchers can gain insights into the roles of cholinergic neurotransmission in disorders such as Alzheimer's disease, myasthenia gravis, and other states of neuromuscular dysfunction. This knockout model can also aid in the development of neuroprotective therapies and the understanding of drug interactions in pharmacogenomics.

The scientific importance of BCHE Gene Knockout Cell Lines extends into both research and clinical settings, where they can be instrumental in drug discovery and development, toxicology studies, and the elucidation of mechanisms underlying cholinergic dysfunction. Compared to traditional cell lines which express the BCHE gene, these knockout models facilitate a more precise understanding of cholinergic mechanisms without the confounding variables introduced by residual enzyme activity.

What sets BCHE Gene Knockout Cell Lines apart from alternative models is their customization potential, reproducibility, and the comprehensive characterization of their phenotypic alterations. These cell lines offer researchers a robust platform to stimulate choline esterase-related pathways, thereby enhancing the predictive value of preclinical studies.

For researchers and clinicians dedicated to advancing the understanding of cholinergic signaling, BCHE Gene Knockout Cell Lines provide essential experimental capabilities that enhance scientific inquiry. Our company stands at the forefront of biological innovation, with a commitment to delivering high-quality genetic tools and resources that support groundbreaking research in cellular biology and therapeutic development.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.